Prognostic Scores for Sorafenib-Treated Hepatocellular Carcinoma Patients: A New Application for the Hepatoma Arterial Embolisation Prognostic Score

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2017.08.036
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Prognostic Score for Patients With Intermediate-Stage Hepatocellular Carcinoma Treated With Transarterial Chemoembolization

PLoS ONE
Multidisciplinary
2015English

The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Discrimination Value of the New Western Prognostic System (CLIP Score) for Hepatocellular Carcinoma in 662 Japanese Patients

Hepatology
MedicineHepatology
2001English

Prognostic Factors for Hepatocellular Carcinoma Recurrence

World Journal of Gastroenterology
MedicineGastroenterology
2014English

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients With Hepatocellular Carcinoma Treated With Sorafenib: A Multicenter Retrospective Study

Internal Medicine
Internal MedicineMedicine
2019English

Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Reply: A Morpho-Molecular Prognostic Model for Hepatocellular Carcinoma

British Journal of Cancer
Cancer ResearchOncology
2013English

SLC2A2 (GLUT2) as a Novel Prognostic Factor for Hepatocellular Carcinoma

Oncotarget
Oncology
2017English

Transcatheter Arterial Chemoembolization After Stopping Sorafenib Therapy for Advanced Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy